However, seizures and musculoskeletal symptoms have been more commonly reported, and congenital heart defects are less frequent in MAP2K1-related CFC (Dentici et al., 2009; Leoni et al., 2021; Pierpont et al., 2022). Here, MAP2K1 is linked to cardiofaciocutaneous syndrome.